Anees Bahji

April 1, 2026

Cannabis Use Disorder in the Era of Legalization: Implications for Addiction Treatment Systems

Abstract Introduction: Cannabis legalization has expanded rapidly across high-income jurisdictions, altering patterns of cannabis use, product potency, and commercial markets.…

June 6, 2025

Long-term, bidirectional associations between depressive symptom severity and opioid use among people with HIV: A prospective cohort study

Abstract Time-lagged associations between opioid use and depressive symptoms were significant. Moderate depressive symptoms predicted greater subsequent opioid use frequency.…

May 6, 2024

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l’humeur et de l’anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

Abstract Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) last published clinical guidelines for the management of major…

May 6, 2022

Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study

Abstract Background: The association between cannabis use and HIV-1 RNA (viral load) among people with HIV (PWH) engaged in care…

March 14, 2022

Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

Abstract Aim: We undertook this systematic review to determine the efficacy and safety of cannabis-based medicine as a treatment for…